# Florida Cancer Specialists & Research Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/florida-cancer-specialists-and-research-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 86.5 |
| Citations | 179,935 |
| City | Port Charlotte |
| Country | US |
| Description | Florida Cancer Specialists & Research Institute is a research organisation in Port Charlotte, US. OpenAlex records 1,574 works and 179,935 citations for it. 324 researchers list it as their most recent affiliation. |
| Homepage | https://www.flcancer.com/ |
| OpenAlex ID | https://openalex.org/I4210118420 |
| Region | Florida |
| Researchers | 324 |
| ROR ID | https://ror.org/02px37122 |
| Type | healthcare |
| Works | 1,574 |

## University papers

Showing 12 of 24.

- [Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer](https://scholariq.org/papers/niraparib-maintenance-therapy-in-platinum-sensitive-recurrent-ovarian-cancer/)
- [Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/incorporation-of-bevacizumab-in-the-primary-treatment-of-ovarian-cancer/)
- [Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix](https://scholariq.org/papers/concurrent-chemotherapy-and-pelvic-radiation-therapy-compared-with-pelvic/)
- [Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Improved Survival with Bevacizumab in Advanced Cervical Cancer](https://scholariq.org/papers/improved-survival-with-bevacizumab-in-advanced-cervical-cancer/)
- [Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer](https://scholariq.org/papers/pembrolizumab-for-persistent-recurrent-or-metastatic-cervical-cancer/)
- [Carcinogenic human papillomavirus infection](https://scholariq.org/papers/carcinogenic-human-papillomavirus-infection/)
- [Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-ii-trial-of-bevacizumab-in-persistent-or-recurrent-epithelial-ovarian/)
- [Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer](https://scholariq.org/papers/dostarlimab-for-primary-advanced-or-recurrent-endometrial-cancer/)
- [Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-iii-trial-of-four-cisplatin-containing-doublet-combinations-in-stage-ivb/)
- [Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)](https://scholariq.org/papers/bevacizumab-for-advanced-cervical-cancer-final-overall-survival-and-adverse/)
- [Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer](https://scholariq.org/papers/analysis-of-gene-expression-profiles-in-normal-and-neoplastic-ovarian-tissue/)

## University researchers

- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.